Therapeutic Development (Drug Discovery) Equipment
-
based in GERMANY
FragAI is an automated workflow for generation of active molecules for therapeutics development using chemoinformatics, bioinformatics and machine learning. Our methodology uses the data flow from SmartSoak and FastForward output. The step of fragment hit expansion and evolution builds on validated fragment hits. The sampled chemical space ...
-
Manufactured by Realize Therapeutics Corp.based in USA
SIBO is a condition related to excess numbers of bacteria in the small intestine, and can be linked to Irritable Bowel Syndrome, Research clearly shows that certain microbes are very effective at treating SIBO and related issues. Realize Therapeutics is developing formulas to address these health ...
-
Manufactured by ASC Therapeuticsbased in USA
gene to a precise location in the genome for safe and optimal expression of the therapeutic protein. We are applying the optimized CRISPR-Cas9 and in-house-developed TARGATT™ gene editing technologies for therapeutic development, focusing on improving both the potency and specificity of ...
-
based in USA
Novel IL-2 approaches and technologies are driving innovation in the therapeutic development space. The IL-2 pathway influences critical aspects of both immune stimulation and immune regulation, through the development and expansion of regulatory T cells ...
-
Manufactured by Neutron Therapeutics, Inc.based in USA
Neutron Therapeutics has developed an accelerator-based, in-hospital neutron source to replace the previously required nuclear reactor. This source is composed of a 2.6 MeV electrostatic proton accelerator and a rotating, solid lithium target for generating neutrons. Neutron Therapeutics will provide this neutron source as part of a ...
-
based in USA
Natural killer (NK) cells, as their name implies, play an important role in ridding the body of cancer and viruses. NK cells are emerging as an increasingly important cell type for therapeutic development. Solid tumors are particularly challenging to treat and CAR-T cells have largely underperformed in the solid tumor setting. NK cells, ...
-
Manufactured by Microviable Therapeutics SLbased in SPAIN
Microviable Therapeutics is developing novel technologies and next generation biotherapeutic products by harnessing the treasure of the human microbiota generating innovative solutions that enable to address unmet challenges in human ...
-
Manufactured by Genscriptbased in USA
cPass Neutralization Antibody Detection kit detects circulating neutralizing antibodies against SARS-CoV-2 that block the interaction between the receptor binding domain (RBD) of the viral spike glycoprotein with the ACE2 cell surface receptor. This kit would be instrumental in vaccine and therapeutic development as it is suitable for all ...
-
Manufactured by PharmAbcine Inc.based in SOUTH KOREA
PharmAbcine’s fully human antibody library provides the diversity of antibody candidates for target antigens, ensuring highest success rates of developing therapeutic antibodies for various indications. Our unique and diverse antibody repertoires are constructed by recombination of V gene segments and DJ gene segments in human B-cell ...
-
Manufactured by Catalent, Incbased in USA
, with 160+ clinical trials utilizing therapeutic candidates developed using GPEx technology and 16 commercially-approved products. ...
-
Manufactured by ProImmune Ltd.based in UNITED KINGDOM
A clear solution to a long-standing problem. Detecting and targeting specific MHC-peptide complexes is of material interest for understanding many disease conditions better and for developing novel therapeutic interventions. It has been very challenging to develop antibodies that bind selectively to an MHC-peptide combination over a more ...
-
Manufactured by Gritstone Biobased in USA
We are leveraging EDGE to define targets for T-cell receptor (TCR) directed cell therapies. These additional targets that were identified and validated by Gritstone EDGE™ enable us to partner with others or develop additional therapeutic approaches to redirect T cells onto tumors using these highly specific ...
-
Manufactured by Jointechlabs Inc.based in USA
Based on our platform and technology, Jointechlabs is developing therapies for unmet medical needs. Our first therapeutic in clinical development JTL-T-01 is a proprietary injectable stem cell scaffold as a biologic therapy for osteoarthritis, for approval under the FDA’s fast-track program. JTL-T-01 has been designed as an autologous ...
-
based in USA
Our AI-enabled Enterprise Platform radically accelerates product development of therapeutics, high value chemicals, and agricultural products. From food to pharmaceuticals, from fuels to fabrics, shorten your time to market by harnessing the full power of artificial intelligence. Start-to-Finish Solution: A single platform for ...
-
based in CANADA
Zucara Therapeutics is developing ZT-01, a first-in-class, once-daily therapeutic to prevent insulin-induced hypoglycemia in patients using insulin therapy. ZT-01 is designed to inhibit somatostatin, a pancreatic hormone that impairs the glucagon response to hypoglycemia in people with insulin dependent diabetes. ZT-01 restores glucagon ...
-
based in USA
The first patient was dosed with our investigational genome editing treatment for transthyretin (ATTR) amyloidosis in November 2020. Our modular approach enables us to optimize the power and versatility of the CRISPR/Cas9 technology and, importantly, allows us to rapidly develop therapeutics for numerous diseases that currently have ...
-
Manufactured by Eliaz Therapeuticsbased in USA
Acute Kidney Injury (AKI) and sepsis are major public health concerns, with high incidence, mortality and morbidity. Despite efforts to develop new interventions, current therapeutic options are limited in scope and effectiveness. At Eliaz Therapeutics, we have developed a patented, unique medical device that will remove ...
-
Manufactured by Ardigenbased in POLAND
Quick solution for effective immune responses in clinical trials; We have created an Artificial Intelligence platform dedicated to being a part of the therapeutic cancer vaccine development. The ArdImmune Vax platform uses sequencing data to generate and prioritize antigen targets for cancer vaccines and T-cell ...
-
Manufactured by Xenobiotic Detection Systems International, Inc.based in USA
disease and it has become an important new target for the development of therapeutic chemicals. Since the AhR can be activated/inhibited by a broad range of structurally diverse natural and synthetic chemicals, high-throughput AhR-responsive cell-based reporter gene bioassays, such as CALUX, are needed provide a relatively rapid and sensitive ...
-
Manufactured by SFA Therapeutics, Inc.based in USA
SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you